The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy.
 
Jennifer Ann Wargo
Leadership - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Honoraria - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Consulting or Advisory Role - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
Speakers' Bureau - Novartis; Genetech
Research Funding - BMS; Genetech; Novartis; GSK (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Genentech, Novartis, Dava Oncology, Bristol Myers Squibb, Illumina
 
Vancheswaran Gopalakrishnan
Patents, Royalties, Other Intellectual Property - MD Anderson Cancer Center
 
Christine Spencer
No Relationships to Disclose
 
Tatiana Karpinets
No Relationships to Disclose
 
Alexandre Reuben
No Relationships to Disclose
 
Miles Cameron Andrews
No Relationships to Disclose
 
Michael T. Tetzlaff
Consulting or Advisory Role - Myriad Genetics
 
Alexander Lazar
Leadership - Archer
Honoraria - Novartis
Consulting or Advisory Role - Novartis
 
Patrick Hwu
Stock and Other Ownership Interests - immatics; Lion Biotechnologies
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Genentech (Inst)
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Isabella Claudia Glitza
Travel, Accommodations, Expenses - Lilly
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Sapna Pradyuman Patel
Stock and Other Ownership Interests - Provectus
Honoraria - Dava Oncology; PCME, Rockpointe; PlatformQ Health
Consulting or Advisory Role - Amgen; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb (Mexico); Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Mexico); Merck
 
Jeffrey Edwin Lee
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Jeffrey E. Gershenwald
Consulting or Advisory Role - Castle Biosciences; Merck
Patents, Royalties, Other Intellectual Property - mercator therapeutics
 
Andrew Futreal
No Relationships to Disclose
 
Padmanee Sharma
Stock and Other Ownership Interests - Evelo Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company; Kite, a Gilead company (I); Neon Therapeutics; Neon Therapeutics (I)
Consulting or Advisory Role - Amgen; Amgen (I); AstraZeneca; AstraZeneca (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); Constellation Pharmaceuticals; Constellation Pharmaceuticals (I); EMD Serono; EMD Serono (I); Evelo Therapeutics; Evelo Therapeutics (I); GlaxoSmithKline; GlaxoSmithKline (I); Jounce Therapeutics; Jounce Therapeutics (I); Kite, a Gilead company; Kite, a Gilead company (I); Neon Therapeutics; Neon Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Own patent licensed to Jounce; Own patents licensed to BMS, Jounce & Merck (I)
 
James Patrick Allison
Patents, Royalties, Other Intellectual Property - Inventor of a patent held by the University of California, Berkeley, and licensed to Bristol Meyers-Squibb; Inventor of a patent owned by Memorial Sloan-Kettering Cancer Center and licensed by Jounce Therapeutics
 
Robert R. Jenq
No Relationships to Disclose